In one of the latest complaints filed against GlaxoSmithKline LLC over the anti-nausea drug Zofran (ondansetron), a family from Louisiana claims that the drug caused their two children to be born with heart defects. Zofran (ondansetron) was first approved by the FDA in 1991 for use in cancer patients undergoing chemotherapy or radiation therapy and later to treat post-operative related nausea and vomiting. The drug company, however, has been accused of marketing the drug for pregnant women experiencing morning sickness and for failing to warn patients of potential health risks.
Plaintiffs’ firm Grant & Eisenhofer filed some of the first cases in the Zofran (ondansetron) MDL, and serves as co-lead on the Plaintiffs’ Executive Committee in the MDL. If you or a loved one took Zofran (ondansetron) for morning sickness during your first trimester and your baby was born with a cleft palate or congenital heart defect, please contact us at 877-978-0169 for a confidential evaluation of your potential claim.